(19)
(11) EP 4 561 530 A1

(12)

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23753826.9

(22) Date of filing: 28.07.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 31/00(2006.01)
A61K 47/20(2006.01)
A61P 7/02(2006.01)
A61K 9/19(2006.01)
A61K 47/02(2006.01)
A61K 47/26(2006.01)
A61P 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0019; A61K 9/19; A61K 47/02; A61K 47/20; A61K 47/26; A61P 7/02; A61P 9/10; A61K 31/506
(86) International application number:
PCT/EP2023/070991
(87) International publication number:
WO 2024/023295 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 29.07.2022 EP 22187889

(71) Applicant: Artorange Ltd.
3083 Limassol (CY)

(72) Inventors:
  • ROLAVA, Evija
    2114 Olaine, Olaine district (LV)
  • PITKEVICA, Olga
    2114 Olaine, Olaine district (LV)
  • SKRIVELIS, Vitalijs
    2114 Olaine, Olaine district (LV)
  • KRAUKLIS, Vjaceslavs
    3083 Limassol (CY)
  • ARSENIAN, Sergey
    3083 Limassol (CY)

(74) Representative: Ullrich & Naumann PartG mbB 
Schneidmühlstrasse 21
69115 Heidelberg
69115 Heidelberg (DE)

   


(54) IMATINIB FORMULATION FOR PARENTERAL ADMINISTRATION